15-96331144-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021005.4(NR2F2):c.-962C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0434 in 1,075,652 control chromosomes in the GnomAD database, including 2,131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 358 hom., cov: 30)
Exomes 𝑓: 0.042 ( 1773 hom. )
Consequence
NR2F2
NM_021005.4 5_prime_UTR
NM_021005.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.01
Genes affected
NR2F2 (HGNC:7976): (nuclear receptor subfamily 2 group F member 2) This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 15-96331144-C-T is Benign according to our data. Variant chr15-96331144-C-T is described in ClinVar as [Benign]. Clinvar id is 1262787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NR2F2 | NM_021005.4 | c.-962C>T | 5_prime_UTR_variant | 1/3 | ENST00000394166.8 | ||
NR2F2 | NM_001145155.2 | c.44-2932C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NR2F2 | ENST00000394166.8 | c.-962C>T | 5_prime_UTR_variant | 1/3 | 1 | NM_021005.4 | P1 | ||
NR2F2 | ENST00000421109.6 | c.44-2932C>T | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0542 AC: 7956AN: 146876Hom.: 360 Cov.: 30
GnomAD3 genomes
AF:
AC:
7956
AN:
146876
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0418 AC: 38778AN: 928672Hom.: 1773 Cov.: 16 AF XY: 0.0419 AC XY: 18271AN XY: 436106
GnomAD4 exome
AF:
AC:
38778
AN:
928672
Hom.:
Cov.:
16
AF XY:
AC XY:
18271
AN XY:
436106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0541 AC: 7954AN: 146980Hom.: 358 Cov.: 30 AF XY: 0.0561 AC XY: 4011AN XY: 71534
GnomAD4 genome
AF:
AC:
7954
AN:
146980
Hom.:
Cov.:
30
AF XY:
AC XY:
4011
AN XY:
71534
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at